Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis
- PMID: 7942325
- DOI: 10.1007/BF02001912
Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis
Abstract
Most of the previous studies dealing with the effect of nonsteroidal anti-inflammatory drugs (NSAIDs) on the synthesis of inflammatory mediators involved in joint damage have been done in cells cultured in vitro or in blood cells from patients treated for short periods of time. In this work we have evaluated the long-term effect of aceclofenac, a new NSAID, and diclofenac on the production of a series of inflammatory mediators by blood cells from 30 patients with severe knee osteoarthritis. Both aceclofenac and diclofenac significantly inhibited prostaglandin E2 (PGE2) synthesis by blood mononuclear and polymorphonuclear cells after 180 days of treatment. However, no clear effect was noted on leukotriene B4 (LTB4) and platelet activating factor (PAF) production. The generation of O-2 by polymorphonuclear cells, stimulated with FMLP, was decreased after 15 days of treatment with both drugs, but reached normal values after 180 days. Interleukin-1 beta (IL-1 beta) production decreased significantly at 180 days with both drugs in the group of high producer patients. In a few (n = 3) patients with high basal mononuclear cell tumor necrosis factor alpha (TNF alpha) production, this also decreased on treatment for 180 days with the NSAIDs. In the remaining low TNF alpha-producing patients, TNF alpha production tended to increase. Interleukin-6 (IL-6) synthesis was not affected by aceclofenac while it was diminished by diclofenac. The decrease in IL-6 in all treated patients was significantly correlated with a worsening of the clinical condition. On the whole, these data could afford a pathogenetic basis for the long-term employment of these drugs in patients with inflammatory conditions.
Similar articles
-
Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease.Drugs. 2001;61(9):1351-78. doi: 10.2165/00003495-200161090-00012. Drugs. 2001. PMID: 11511027 Review.
-
In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators.Inflamm Res. 2001 Aug;50(8):391-9. doi: 10.1007/PL00000261. Inflamm Res. 2001. PMID: 11556519
-
Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes.J Rheumatol. 2001 Dec;28(12):2692-9. J Rheumatol. 2001. PMID: 11764219
-
Inhibition of the production of platelet activating factor and of leukotriene B4 in activated neutrophils by nimesulide due to an elevation of intracellular cyclic adenosine monophosphate.Arzneimittelforschung. 1995 Oct;45(10):1110-4. Arzneimittelforschung. 1995. PMID: 8595070
-
[What is the role of aceclofenac in the therapeutic arsenal against chronic osteoarthritis pathologies?].Rev Med Liege. 2001 Jul;56(7):484-8. Rev Med Liege. 2001. PMID: 11523298 Review. French.
Cited by
-
Psychoneuroimmunological relationships in women with fibromyalgia.Biol Res Nurs. 2013 Apr;15(2):219-25. doi: 10.1177/1099800411424204. Epub 2011 Dec 15. Biol Res Nurs. 2013. PMID: 22174319 Free PMC article.
-
[Update of rheumatology--II. State and prospectives of chemotherapy in chronic arthritis].Med Klin (Munich). 1999 Oct 15;94(10):556-63. doi: 10.1007/BF03044953. Med Klin (Munich). 1999. PMID: 10554514 Review. German. No abstract available.
-
A Review of Chronic Musculoskeletal Pain: Central and Peripheral Effects of Diclofenac.Pain Ther. 2018 Dec;7(2):163-177. doi: 10.1007/s40122-018-0100-2. Epub 2018 Jun 5. Pain Ther. 2018. PMID: 29873010 Free PMC article. Review.
-
Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: effect of the nonsteroidal anti inflammatory drugs indomethacin, diclofenac and naproxen.Inflamm Res. 1995 Nov;44(11):486-90. doi: 10.1007/BF01837915. Inflamm Res. 1995. PMID: 8597883 Clinical Trial.
-
Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease.Drugs. 2001;61(9):1351-78. doi: 10.2165/00003495-200161090-00012. Drugs. 2001. PMID: 11511027 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical